BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Li J, Li N, Lu M, Wen S, Zhan X. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas. EPMA J 2020;11:419-67. [PMID: 32849927 DOI: 10.1007/s13167-020-00215-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rai A, Yelamanchi SD, Radotra BD, Gupta SK, Mukherjee KK, Tripathi M, Chhabra R, Ahuja CK, Kumar N, Pandey A, Korbonits M, Dutta P, Gaston-massuet C. Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours. acta neuropathol commun 2022;10. [DOI: 10.1186/s40478-022-01441-5] [Reference Citation Analysis]
2 Thongboonkerd V, Chaiyarit S. Gel-Based and Gel-Free Phosphoproteomics to Measure and Characterize Mitochondrial Phosphoproteins. Curr Protoc 2022;2:e390. [PMID: 35275445 DOI: 10.1002/cpz1.390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wen S, Li C, Zhan X. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00274-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cheng L, Rao Q, Zhang Q, Song W, Guan S, Jiang Z, Wu T, Zhao Z, Song W. The immunotoxicity of decabromodiphenyl ether (BDE-209) on broiler chicks by transcriptome profiling analysis. Ecotoxicol Environ Saf 2022;232:113284. [PMID: 35149409 DOI: 10.1016/j.ecoenv.2022.113284] [Reference Citation Analysis]
5 Aydin B, Caliskan A, Arga KY. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies. EPMA J 2021;12:383-401. [PMID: 34567287 DOI: 10.1007/s13167-021-00246-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rai A, Das L, Mukherjee KK, Dhandapani S, Tripathi M, Ahuja CK, Radotra BD, Dutta P. Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas. Front Endocrinol (Lausanne) 2021;12:708111. [PMID: 34295309 DOI: 10.3389/fendo.2021.708111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li N, Desiderio DM, Zhan X. The use of mass spectrometry in a proteome-centered multiomics study of human pituitary adenomas. Mass Spectrom Rev 2021. [PMID: 34109661 DOI: 10.1002/mas.21710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li B, Wang X, Yang C, Wen S, Li J, Li N, Long Y, Mu Y, Liu J, Liu Q, Li X, Desiderio DM, Zhan X. Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches. EPMA J 2021;12:67-89. [PMID: 33786091 DOI: 10.1007/s13167-021-00232-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Carrillo-Najar C, Rembao-Bojórquez D, Tena-Suck ML, Zavala-Vega S, Gelista-Herrera N, Ramos-Peek MA, Gómez-Amador JL, Cazares-Raga F, Hernández-Hernández FC, Ortiz-Plata A. Comparative Proteomic Study Shows the Expression of Hint-1 in Pituitary Adenomas. Diagnostics (Basel) 2021;11:330. [PMID: 33671384 DOI: 10.3390/diagnostics11020330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li J, Zhan X. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas. Biochim Biophys Acta Proteins Proteom 2021;1869:140584. [PMID: 33321259 DOI: 10.1016/j.bbapap.2020.140584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]